Liquid purification or separation – Processes – Liquid/liquid solvent or colloidal extraction or diffusing...
Patent
1991-07-15
1992-04-28
Sever, Frank
Liquid purification or separation
Processes
Liquid/liquid solvent or colloidal extraction or diffusing...
210652, B01D 6114
Patent
active
051086131
ABSTRACT:
By ultrafiltration of an aqueous solution wherein there have been formerly dissolved alfa-cyclodextrin and a raw lipidic mixture, the latter characterized in that it contains monosialoganglioside (GM1) either as the sole ganglioside or otherwise in a prevailing quantity over the other associated gangliosides, and after the removal of cyclodextrin at the end of the process, it is obtained GM1 with a titer of at least 95%. The present invention concerns also the intermediate complex that it is being formed between the hereabove said monosialoganglioside and alfa-cyclodextrin.
REFERENCES:
patent: 4868291 (1989-09-01), Yokoyama et al.
Carbohydrate Research, vol. 179, 1988, pp. 393-410, Elsevier Science Publishers B.V., Amsterdam et al, "Synthesis and characterization of lyso-GM3 (II3Neu5Ac lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl cer), and related compounds".
Biochem. J., vol. 88, 1963, pp. 373-383; D. B. Gammack: "Physicochemical properties of ox-brain gangliosides".
Casu Benito
Cedro Armando
Lanzarotti Ennio
Naggi Annamaria
Torri Giangiacomo
Crinos Industria Farmacobiologica S.p.A.
Sever Frank
LandOfFree
Process for the isolation and purification of monosialogangliosi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the isolation and purification of monosialogangliosi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the isolation and purification of monosialogangliosi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246608